BMRN vs PCOR · P/E 40, rev $2.85B vs rev $1.15B
Biomarin Pharmaceutical Inc (BMRN) versus Procore Technologies Inc (PCOR) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Procore Technologies Inc (PCOR) is a software - application company listed on NYSE.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported PCOR revenue for 2024-12-31 was $1.15B. Net income was -$106.0M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. PCOR currently screens at market cap $5.88B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. PCOR currently screens at market cap $5.88B.
Not investment advice. Open the BMRN and PCOR stock pages for the full models.
Not investment advice.